Time to generalization and prediction of survival in patients with amyotrophic lateral sclerosis: a retrospective observational study
- 25 March 2016
- journal article
- research article
- Published by Wiley in European Journal of Neurology
- Vol. 23 (6) , 1117-1125
Abstract
Background and purpose: A strong association between time to generalization (TTG), considered as the time of spreading of the clinical signs from spinal or bulbar localization to both, and survival was recently identified in patients with amyotrophic lateral sclerosis (ALS). Thus, TTG may be used as an early to intermediate end‐point in survival studies. The aim of the present study was to test TTG as a predictor of survival in ALS.Methods: This was an observational retrospective study of ALS patients from a tertiary referral centre over a 5‐year follow‐up period.Results: In 212 ALS patients, TTG was associated with time to death/tracheostomy [R 0.62, 95% confidence interval (CI) 0.53–0.70; P < 0.001]. In a time‐to‐event analysis, longer TTG resulted in lower risk to reach a composite outcome (death or tracheostomy) both in univariate [hazard ratio (HR) 0.98, 95% CI 0.97–0.99] and multivariate Cox analyses (HR 0.98, 95% CI 0.96–0.99). TTG predicted death/tracheostomy at 4 years (C‐statistic 0.58; 95% CI 0.53–0.63) and at 5 years (C‐statistic 0.58; 95% CI 0.53–0.62).Conclusions: Based on the present results from a large clinical cohort, TTG may be used as a new early to intermediate end‐point to describe the ALS natural history. TTG may be potentially useful as a new primary outcome measure for clinical trials.Keywords
Funding Information
- Seventh Framework Programme (FP7/2007-2013, 259867)
This publication has 40 references indexed in Scilit:
- The Seeds of Neurodegeneration: Prion-like Spreading in ALSCell, 2011
- Prion-like propagation of mutant superoxide dismutase-1 misfolding in neuronal cellsProceedings of the National Academy of Sciences, 2011
- The epidemiology and treatment of ALS: Focus on the heterogeneity of the disease and critical appraisal of therapeutic trialsAmyotrophic Lateral Sclerosis, 2010
- Toward more efficient clinical trials for amyotrophic lateral sclerosisAmyotrophic Lateral Sclerosis, 2009
- ALS motor phenotype heterogeneity, focality, and spreadNeurology, 2009
- Descriptive epidemiology of amyotrophic lateral sclerosis: new evidence and unsolved issuesJournal of Neurology, Neurosurgery & Psychiatry, 2008
- The effect of noninvasive ventilation on ALS patients and their caregiversNeurology, 2006
- Survival of patients with ALS following institution of enteral feeding is related to pre‐procedure oximetry: A retrospective review of 98 patients in a single centreAmyotrophic Lateral Sclerosis, 2006
- Amyotrophic lateral sclerosis: a consensus viewpoint on designing and implementing a clinical trialAmyotrophic Lateral Sclerosis, 2004
- Early symptom progression rate is related to ALS outcomeNeurology, 2002